5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum

C37H26N5OPtSe-3 — CID 168840564

IUPAC5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum
SMILES[2H]C([2H])([2H])N1[CH-]N(c2[c-]c(Oc3[c-]c4c(cc3)[Se]c3ncccc3N4c3cc(C)c(-c4ccccc4)cn3)ccc2)c2ccccc21.[Pt]
InChIInChI=1S/C37H26N5OSe.Pt/c1-25-20-36(39-23-30(25)26-10-4-3-5-11-26)42-33-16-9-19-38-37(33)44-35-18-17-29(22-34(35)42)43-28-13-8-12-27(21-28)41-24-40(2)31-14-6-7-15-32(31)41;/h3-20,23-24H,1-2H3;/q-3;/i2D3;
InChIKeyCSBRCFRKOPMTFS-MUTAZJQDSA-N
MW833.71 g/mol
LogP6.99
Rot. Bonds6

About 5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum

5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum (PubChem CID 168840564) has the molecular formula C37H26N5OPtSe-3 and a molecular weight of 833.71 g/mol. Its IUPAC name is 5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum.

Molecular Properties

Compound Name5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum
PubChem CID168840564
Molecular FormulaC37H26N5OPtSe-3
Molecular Weight833.71 g/mol
Exact Mass834.12
IUPAC Name5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum
SMILES[2H]C([2H])([2H])N1[CH-]N(c2[c-]c(Oc3[c-]c4c(cc3)[Se]c3ncccc3N4c3cc(C)c(-c4ccccc4)cn3)ccc2)c2ccccc21.[Pt]
InChIInChI=1S/C37H26N5OSe.Pt/c1-25-20-36(39-23-30(25)26-10-4-3-5-11-26)42-33-16-9-19-38-37(33)44-35-18-17-29(22-34(35)42)43-28-13-8-12-27(21-28)41-24-40(2)31-14-6-7-15-32(31)41;/h3-20,23-24H,1-2H3;/q-3;/i2D3;
InChIKeyCSBRCFRKOPMTFS-MUTAZJQDSA-N
XLogP6.99
TPSA44.73 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500833.71
LogP ≤ 56.99
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum?
The IUPAC name of 5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum (CID 168840564) is 5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum.
What is the SMILES notation for 5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum?
The canonical SMILES for 5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum is [2H]C([2H])([2H])N1[CH-]N(c2[c-]c(Oc3[c-]c4c(cc3)[Se]c3ncccc3N4c3cc(C)c(-c4ccccc4)cn3)ccc2)c2ccccc21.[Pt].
What is the InChIKey of 5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum?
The InChIKey is CSBRCFRKOPMTFS-MUTAZJQDSA-N. The full InChI is InChI=1S/C37H26N5OSe.Pt/c1-25-20-36(39-23-30(25)26-10-4-3-5-11-26)42-33-16-9-19-38-37(33)44-35-18-17-29(22-34(35)42)43-28-13-8-12-27(21-28)41-24-40(2)31-14-6-7-15-32(31)41;/h3-20,23-24H,1-2H3;/q-3;/i2D3;.
What are the key properties of 5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum?
5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum has a molecular weight of 833.71 g/mol, XLogP of 6.99, 6 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(4-methyl-5-phenyl-2-pyridinyl)-7-[3-[3-(trideuteriomethyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-6H-pyrido[2,3-b][1,4]benzoselenazin-6-ide;platinum is sourced from PubChem (CID 168840564), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).